Today: 7 February 2026
Subscribe
Browse Category

Mergers & Acquisitions News 26 December 2025 - 30 December 2025

DigitalBridge stock jumps as SoftBank agrees $4 billion buyout at $16 a share

DigitalBridge stock jumps as SoftBank agrees $4 billion buyout at $16 a share

NEW YORK, December 30, 2025, 05:23 ET — Premarket DigitalBridge Group Inc (NYSE:DBRG) shares climbed 9.7% to $15.26 in premarket trading on Tuesday after SoftBank Group said it would buy the digital infrastructure investment manager in an all-cash deal. The acquisition lands as Wall Street’s focus on AI infrastructure shifts from chips to the physical plumbing behind them — data centers, fiber and power — areas where demand can rise quickly but capacity takes years and billions to build. “As AI transforms industries worldwide, we need more compute, connectivity, power, and scalable infrastructure,” SoftBank Chairman and CEO Masayoshi Son said.
30 December 2025
···
DigitalBridge stock jumps nearly 10% on SoftBank’s $4 billion buyout offer — what investors watch next

DigitalBridge stock jumps nearly 10% on SoftBank’s $4 billion buyout offer — what investors watch next

NEW YORK, December 30, 2025, 00:11 ET — Market closed DigitalBridge Group, Inc. shares jumped 9.7% to $15.27 on Monday after SoftBank Group said it would buy the digital infrastructure investor for about $4 billion, or $16 a share in cash. SoftBank said the offer represents a 15% premium to DigitalBridge’s Dec. 26 close and about 50% to the stock’s “unaffected” 52-week average closing price as of Dec. 4. About 86 million shares changed hands, far above recent averages. Nasdaq+1 The deal lands at a moment when investors are trying to put a price on the plumbing behind the AI
30 December 2025
···
Constellation Energy stock today: CEG slips in thin year-end trade as Calpine deal stays in focus

Constellation Energy stock today: CEG slips in thin year-end trade as Calpine deal stays in focus

NEW YORK, December 29, 2025, 23:50 ET — Market closed Constellation Energy Corp shares slipped 0.6% on Monday, ending at $358.33 as trading volumes thinned in the final week of the year. The dip matters because Constellation has become a proxy for the U.S. power-demand boom tied to artificial intelligence data centers, which are pushing grid planners and regulators to focus on supply constraints and reliability. That backdrop has kept power producers in the spotlight even on quiet sessions, with investors balancing long-term demand themes against near-term catalysts such as regulatory milestones and financing steps tied to big deals. Constellation
30 December 2025
·······
JNJ stock today: J&J closes $3.05B Halda cancer deal, flags EPS hit — what’s next

JNJ stock today: J&J closes $3.05B Halda cancer deal, flags EPS hit — what’s next

NEW YORK, December 29, 2025, 20:26 ET — Market closed Johnson & Johnson (JNJ) shares were last down 0.02% at $207.56 on Monday after the healthcare conglomerate said it completed its $3.05 billion cash acquisition of cancer drug developer Halda Therapeutics. The stock traded between $207.31 and $209.46, and J&J said it will account for the deal as a business combination and expects it to cut adjusted earnings per share by about $0.20, split evenly between the fourth quarter and 2026. JNJ.com The closing matters because it adds another pipeline bet in oncology, where big drugmakers are still hunting for
30 December 2025
····
Adobe stock slips after hours as Semrush sets Feb. 3 vote on $12-a-share deal

Adobe stock slips after hours as Semrush sets Feb. 3 vote on $12-a-share deal

NEW YORK, December 29, 2025, 19:44 ET — After-hours Adobe Inc. (ADBE) shares slipped 0.2% to $353.16 in after-hours trading on Monday, a session that runs after the market’s 4 p.m. close. Semrush Holdings said in a definitive proxy statement — the document used to seek shareholder votes — that stockholders of record as of Dec. 26 will vote on Feb. 3 on Adobe’s all-cash offer of $12 a share. The proxy statement is dated Dec. 29 and is first being mailed on or about Dec. 31, the filing showed. The filing puts a firm date on a key hurdle
30 December 2025
····
JNJ stock edges higher after Johnson & Johnson closes $3.05B Halda deal; earnings outlook next

JNJ stock edges higher after Johnson & Johnson closes $3.05B Halda deal; earnings outlook next

NEW YORK, December 29, 2025, 14:38 ET — Regular session Johnson & Johnson shares were up about 0.3% at $208.28 in afternoon trading on Monday after the healthcare conglomerate said it had completed its $3.05 billion cash acquisition of Halda Therapeutics. JNJ.com The close matters because it brings Johnson & Johnson a clinical-stage oncology platform and assets as investors press large drugmakers to keep replenishing their pipelines ahead of patent expirations and pricing pressure. It also puts the focus back on execution: the deal is expected to dent near-term profit metrics, and Johnson & Johnson has flagged its next earnings
29 December 2025
···
Philip Morris stock ticks up on Swedish Match plan filing as U.S. market softens

Philip Morris stock ticks up on Swedish Match plan filing as U.S. market softens

NEW YORK, December 29, 2025, 1:03 PM ET — Regular session Shares of Philip Morris International (PM.N) rose slightly on Monday after the tobacco company filed to register 500,000 shares for a Swedish Match North America employee profit-sharing plan, a filing showed. The stock was up 0.3% at $161.52 in midday New York trading. SEC The small gain stood out in a market that has leaned choppy into the final full week of the year, with investors favoring steadier, cash-generating names over high-growth bets. That matters for Philip Morris holders because the stock is widely owned for its dividends and
29 December 2025
··
WBD stock hovers near takeover price as Jan. 21 tender deadline nears

WBD stock hovers near takeover price as Jan. 21 tender deadline nears

NEW YORK, December 29, 2025, 12:21 ET — Regular session Warner Bros Discovery shares edged higher on Monday, up about 0.2% at $28.86 by 12:21 p.m. ET, as trading stayed anchored around the prices implied by competing takeover proposals. The stock has been effectively “deal-trading” as shareholders weigh a tender offer — a public bid that asks investors to sell their shares at a stated price — from Paramount Skydance against Warner’s agreed transaction with Netflix, ahead of a Jan. 21 deadline for investors to decide on Paramount’s offer. Reuters That countdown matters now because the window for a higher
29 December 2025
·····
SoftBank’s DigitalBridge buyout jolts thin year-end trading as U.S. futures dip

SoftBank’s DigitalBridge buyout jolts thin year-end trading as U.S. futures dip

NEW YORK, December 29, 2025, 09:27 ET Key points: SoftBank Group said on Monday it will acquire digital infrastructure investor DigitalBridge Group in a deal valued at about $4 billion, pushing DigitalBridge shares sharply higher in premarket trading. (Reuters) Reuters The deal lands as Wall Street heads into the final week of the year with lighter volumes and fewer trading days, a setup that can amplify market moves. U.S. markets are shut on Thursday for New Year’s Day. Reuters+1 SoftBank is paying $16 per share, a roughly 15% premium to DigitalBridge’s Friday close, Reuters reported. DigitalBridge managed about $108 billion
29 December 2025
···
Warner Bros Discovery stock stuck between Netflix deal value and Paramount’s $30 bid as Jan. 21 deadline nears

Warner Bros Discovery stock stuck between Netflix deal value and Paramount’s $30 bid as Jan. 21 deadline nears

NEW YORK, December 29, 2025, 03:21 ET — Market closed Warner Bros. Discovery shares last fell 1.4% to $28.80, leaving the stock wedged between competing takeover prices as investors head into Monday’s session waiting for the next headline in the bidding fight. The gap matters because WBD’s share price has become a running read on whether investors expect a sweeter offer, or whether the company’s board will stick with the deal it has already endorsed. Warner Bros. Discovery IR+1 Paramount Skydance’s hostile bid is structured as a tender offer — a proposal to buy shares directly from shareholders — and
29 December 2025
·····
ServiceNow stock edges higher into year-end as $7.75 billion Armis deal stays in focus

ServiceNow stock edges higher into year-end as $7.75 billion Armis deal stays in focus

NEW YORK, December 28, 2025, 21:05 ET — Market closed ServiceNow, Inc. shares ended Friday’s session up 0.8% at $153.89, giving the workflow software maker a small lift into the final trading days of the year. The move matters now because investors are weighing whether ServiceNow’s push into big-ticket dealmaking will strengthen growth without adding unwanted balance-sheet risk, at a time when year-end trading can be choppy and volumes thin. investor.servicenow.com+1 A Bloomberg report on Friday highlighted that ServiceNow has committed at least $12 billion in 2025 to acquisitions or strategic investments, underscoring why the market is parsing each new
29 December 2025
··
BP cashes in on Castrol: $10.1 billion Stonepeak deal sets up Castrol India share offer

BP cashes in on Castrol: $10.1 billion Stonepeak deal sets up Castrol India share offer

NEW YORK, December 28, 2025, 18:42 ET BP has agreed to sell a 65% stake in its Castrol lubricants business to investment firm Stonepeak, valuing the unit at about $10.1 billion on an enterprise basis. Enterprise value is a measure that includes a company’s debt. Stonepeak BP expects the transaction to deliver net proceeds of around $6 billion, including accelerated dividend payments, and said the cash will be used to reduce net debt. WorkBoat The deal also has an immediate knock-on in India, where Stonepeak and Canada Pension Plan Investment Board (CPP Investments) are setting up a mandatory share offer
29 December 2025
··
ServiceNow (NOW) Stock Weekend Update: What Wall Street Is Watching After the $7.75B Armis Deal, CEO Contract Extension, and Fresh Analyst Targets

ServiceNow (NOW) Stock Weekend Update: What Wall Street Is Watching After the $7.75B Armis Deal, CEO Contract Extension, and Fresh Analyst Targets

NEW YORK, Dec. 28, 2025, 10:58 a.m. ET — Market closed New York Stock Exchange ServiceNow, Inc. (NYSE: NOW) heads into the final trading stretch of the year with investors still digesting a major strategic pivot: a blockbuster cybersecurity acquisition, a growing list of deals across 2025, and new signals from Wall Street about how much of that M&A premium the market is willing to pay. Reuters+1 With U.S. stock exchanges closed for the weekend and the NYSE core session set to reopen Monday morning, attention is shifting from day-to-day price moves to the key question that will likely shape
28 December 2025
··
ServiceNow (NOW) Stock Today: Analyst Price Targets, Armis Deal Digest, and What to Watch Before Monday’s Open

ServiceNow (NOW) Stock Today: Analyst Price Targets, Armis Deal Digest, and What to Watch Before Monday’s Open

NEW YORK, Dec. 27, 2025, 4:52 p.m. ET — Market closed ServiceNow, Inc. (NYSE: NOW) stock is heading into the final stretch of 2025 with Wall Street balancing two competing narratives: a year-end equity backdrop still hovering near record territory, and company-specific debate over whether ServiceNow’s cybersecurity expansion—led by its planned Armis acquisition—adds durable growth or introduces execution and financing risk. With the New York Stock Exchange closed for the weekend, the latest actionable reference point is Friday’s close. ServiceNow shares finished the Dec. 26 session at $153.89, up 0.85% on the day, after trading between roughly $152.21 and $154.48.
27 December 2025
··
Warner Bros. Discovery Stock (WBD) Weekend Update: Deal-Arbitrage Tension Builds Ahead of Monday’s Open

Warner Bros. Discovery Stock (WBD) Weekend Update: Deal-Arbitrage Tension Builds Ahead of Monday’s Open

NEW YORK, Dec. 27, 2025, 11:09 a.m. ET — Market Closed Warner Bros. Discovery, Inc. (NASDAQ: WBD) — the company behind HBO, Warner Bros. studios and a portfolio of cable networks — heads into the final full week of 2025 with its stock trading less like a traditional media name and more like a live referendum on a high-stakes takeover fight. With U.S. markets closed for the weekend, investors are left to digest a familiar but still fast-moving setup: a signed Netflix agreement that would reshape WBD’s crown-jewel assets, and a rival Paramount Skydance all-cash tender offer that has been
27 December 2025
····
Global M&A Boom in 2025: Dealmaking Hits $4.5 Trillion as Trump Antitrust Shift Fuels Megadeals and the Warner Bros Bidding War

Global M&A Boom in 2025: Dealmaking Hits $4.5 Trillion as Trump Antitrust Shift Fuels Megadeals and the Warner Bros Bidding War

Wall Street is ending 2025 the way it likes to start a new year: with phones buzzing, lawyers on standby, and bankers quietly admitting that “holiday break” has become more of an aspiration than a schedule. In the final stretch of December alone, $463.6 billion in mergers and acquisitions were announced, according to Dealogic data cited by Reuters—helping turn the year-end lull into one of the busiest dealmaking periods in recent memory. Reuters Behind the surge is a mix of boardroom confidence, buoyant valuations, and an increasingly permissive view of deal risk. But one factor is dominating both headlines and
27 December 2025
·
Merck Stock (MRK) News and Forecasts: FDA Fast-Track Vouchers, TrumpRx Pricing Deal, and Cidara Acquisition in Focus Ahead of the Next Market Session

Merck Stock (MRK) News and Forecasts: FDA Fast-Track Vouchers, TrumpRx Pricing Deal, and Cidara Acquisition in Focus Ahead of the Next Market Session

As of 2:34 a.m. ET in New York on Saturday, December 27, 2025, U.S. stock markets are closed for the weekend.Merck & Co., Inc. (NYSE: MRK) was last quoted around $106.78, up about 0.33% versus its prior close, based on the latest available pricing feed. With year-end trading under way and liquidity often thinner around the holidays, Merck is heading into the next session with an unusually packed headline stack: policy-driven drug pricing news, FDA review acceleration for two experimental therapies, and portfolio diversification via M&A—all against the backdrop of investors constantly re-litigating the same big question: how Merck replaces
27 December 2025
···
WBD Stock Update: Warner Bros. Discovery Shares Hover Near $29 as Netflix Deal, Paramount Bid, and Antitrust Risk Shape the Trade

WBD Stock Update: Warner Bros. Discovery Shares Hover Near $29 as Netflix Deal, Paramount Bid, and Antitrust Risk Shape the Trade

NEW YORK — Dec. 26, 2025 (9:47 p.m. ET) — Warner Bros. Discovery, Inc. Series A Common Stock (NASDAQ: WBD) is heading into the final trading days of the year with a rare combination of forces driving the price: a signed, headline-grabbing deal for its studios and streaming business, a hostile all-cash counterbid for the whole company, and a regulatory review that could determine whether any of it actually closes. Nasdaq WBD ended Friday’s session at $28.80 after a subdued, post-holiday market day on Wall Street. MarketBeat+1 The broader market backdrop was calm—major U.S. indexes finished fractionally lower on light
27 December 2025
····
Netflix Stock (NFLX) Today: Shares Tick Higher as Wall Street Weighs Warner Bros. Deal Financing, Regulatory Risk, and Q4 Earnings Ahead

Netflix Stock (NFLX) Today: Shares Tick Higher as Wall Street Weighs Warner Bros. Deal Financing, Regulatory Risk, and Q4 Earnings Ahead

As of 1:05 p.m. ET in New York on Friday, December 26, 2025, Netflix, Inc. (NASDAQ: NFLX) is trading at $94.22, up about 0.6% on the day in a quiet, post-holiday session. The broader tape is mixed: the S&P 500 ETF (SPY) is fractionally lower while the Nasdaq-100 ETF (QQQ) is roughly flat—typical of thin year-end trading where stock-specific headlines can matter more than macro catalysts. Friday’s backdrop is also unusually seasonal: December 26 historically has been one of the market’s more consistently positive calendar days, and it falls inside the “Santa Claus rally” window that traders watch into year-end.
26 December 2025
···
Abivax (ABVX) Stock in Focus: Eli Lilly Takeover Chatter, Obefazimod Phase 3 Momentum, and What to Watch Before the Next U.S. Session

Abivax (ABVX) Stock in Focus: Eli Lilly Takeover Chatter, Obefazimod Phase 3 Momentum, and What to Watch Before the Next U.S. Session

NEW YORK — Friday, December 26, 2025 (9:13 a.m. ET): U.S. stocks are heading into a thin, post‑Christmas trading day, with Wall Street set for a relatively muted open as investors digest a strong 2025 tape and look ahead to 2026 rate and earnings narratives. Reuters In that kind of tape, headline-driven biotech names can swing harder than usual—and ABIVAX Société Anonyme (NASDAQ: ABVX) has been exactly that kind of stock in December: a mix of clinical-trial enthusiasm, index-related positioning, and renewed takeover speculation. As of the latest available quote this morning, ABVX was trading around $145.31 in the premarket,
26 December 2025
···
1 2 3 … 20

Stock Market Today

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
Go toTop